FDA says Mountain Peak Nutritionals' Mood Support is an unapproved drug and illegally labeled over claims it treats depression and anxiety.
What happened
FDA reviewed www.mountainpeaknutritionals.com in December 2020 and found the company takes orders there for Mood Support. The website and technical data sheet claimed ingredients treat depression and anxiety, including comparing 5-HTP to antidepressant drugs. FDA says those claims make Mood Support a drug, but it is not FDA-approved and lacks adequate directions for use.
What FDA found
FDA says website claims that Mood Support treats depression and anxiety make it a drug intended to cure, mitigate, treat, or prevent disease.
section 201(g)(1)(B) of the Act [21 U.S.C. § 321(g)(1)(B)]FDA says Mood Support is an unapproved new drug because it is not generally recognized as safe and effective for those uses and has no FDA approval.
section 201(p) of the Act [21 U.S.C. § 321(p)]; sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]FDA says Mood Support is misbranded (improperly labeled) because it lacks adequate directions for safe lay use, since its intended uses need a licensed practitioner.
section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]; 21 C.F.R. § 201.5FDA says introducing the misbranded drug into interstate commerce violates the Act.
section 301(a) of the Act [21 U.S.C. § 331(a)]
What FDA wants
FDA tells the company to take prompt action and notify FDA in writing within fifteen working days of receipt, describing the specific steps taken, how recurrence will be prevented, and providing related documents. If it believes there is no violation, it must explain why with supporting information.
Who should pay attention
- supplement companies making depression or anxiety claims
- retailers and online marketplaces that list Mood Support-type products
- marketing teams that compare supplements to prescription antidepressants
This is a summary. Read the original letter on fda.gov.